Trial Search Results

Diagnostic Study of Tumor Characteristics in Patients With Ewing's Sarcoma

Diagnostic trial to study genetic differences in patients who have Ewing's sarcoma. Genetic testing may help predict how cancer will respond to treatment and allow doctors to plan more effective therapy.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Children's Oncology Group

Collaborator: National Cancer Institute (NCI)

Stanford Investigator(s):


  • Other: laboratory biomarker analysis


Inclusion Criteria:

   - Newly diagnosed or recurrent Ewing's sarcoma

   - Availability of the following specimens:

      - Paraffin-embedded block or 20 unstained slides and 1-3 thick (50 micron) sections
      from initial biopsy

      - Pretreatment serum and whole blood

   - Concurrent therapy is not required

Ages Eligible for Study

N/A - 50 Years

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Peds Hem/Onc CRAs
Not Recruiting